Weekly Digest: new photo essay from the Department of Defense (1 item)

Planting Peace With Partners Planting Peace With Partners By Alicia Brown U.S. service members helped cultivate valuable relationships during a recent event to plant "peace trees" in the village of Damerjog, Djibouti. Published February 16, 2022 at 07:00AM View more at https://defense.gov February 17, 2022 at 04:22AM via Department of Defense http://www.defense.gov?CollectionId=19529

Weekly Digest: New diabetes clinical trial (9 items)

New diabetes clinical trial: Heat Therapy in Patients With Type 2 Diabetes Mellitus Published on: February 14, 2022 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   Insulin Resistance Interventions:   Procedure: Passive heating;   Procedure: Thermoneutral Sponsor:   University of Pecs Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05237219?term=diabetes&sfpd_d=14 February 14, 2022 at 05:22PM via ClinicalTrials.gov New diabetes clinical trial: In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes Published on: February 14, 2022 at 07:00PM Condition:   Type 2 Diabetes Treated With Insulin Intervention:   Device: MiniMed™ 780G Insulin Pump system Sponsor:   Medtronic Diabetes Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05238142?term=diabetes&sfpd_d=14 February 14, 2022 at 05:22PM via ClinicalTrials.gov New diabetes clinical trial: Clinical Utility Trial for the SomaLogic CVD-T2D Test Published on: February 14, 2022 at 07:00PM Conditions:   Cardiovascular Diseases;   Type 2 Diabetes Interventions:   Other: Educational Materials on the Cardiovascular Disease in Type 2 Diabetes (CVD-T2D);   Other: Educational Materials on the CVD-T2D and Bundled Metabolic Panel Sponsors:   Qure Healthcare, LLC;   SomaLogic, Inc. Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05237271?term=diabetes&sfpd_d=14 February 14, 2022 at 05:22PM via ClinicalTrials.gov New diabetes clinical trial: Serum Endocan Levels and Gestational Diabetes Published on: February 14, 2022 at 07:00PM Conditions:   Gestational Diabetes;   Endocan Intervention:   Diagnostic Test: Serum Endocan Levels Sponsor:   Gaziosmanpasa Research and Education Hospital Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05237895?term=diabetes&sfpd_d=14 February 14, 2022 at 05:22PM via ClinicalTrials.gov New diabetes clinical trial: The POWERED Study: Prophylaxis With Metformin to Prevent PTDM Published on: February 15, 2022 at 07:00PM Conditions:   Post-transplant Diabetes Mellitus;   New Onset Diabetes After Transplant;   New Onset Diabetes After Transplantation;   Kidney Transplant; Complications;   Renal Transplantation;   End Stage Renal Disease;   Metformin Interventions:   Drug: Metformin;   Drug: Placebo Sponsor:   Barts & The London NHS Trust Active, not recruiting https://clinicaltrials.gov/ct2/show/NCT05240274?term=diabetes&sfpd_d=14 February 15, 2022 at 06:22PM via ClinicalTrials.gov New diabetes clinical trial: Medication Review in Patients With Schizophrenia and Diabetes Published on: February 16, 2022 at 07:00PM Conditions:   Schizophrenia;   Diabetes;   Metabolic Syndrome Intervention:   Other: medication review Sponsors:   Psychiatric Research Unit, Region Zealand, Denmark;   Steno Diabetes Center Sjaelland;   Region Zealand Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05243160?term=diabetes&sfpd_d=14 February 16, 2022 at 04:22PM via ClinicalTrials.gov New diabetes clinical trial: Afrezza With Basal Combination Published on: February 17, 2022 at 07:00PM Condition:   Type 1 Diabetes Interventions:   Biological: Afrezza (insulin human) Inhalation Powder;   Biological: insulin degludec;   Device: Continuous Subcutaneous Insulin Infusion (CSII) pump with Automatic Insulin Delivery (AID) Sponsor:   Mannkind Corporation Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05243628?term=diabetes&sfpd_d=14 February 17, 2022 at 02:23PM via ClinicalTrials.gov New diabetes clinical trial: Effect of Insulin Staging in the Context of Pharmaceutical Care on Patients With Type 2 Diabetes Mellitus Published on: February 17, 2022 at 07:00PM Condition:   Type 2 Diabetes Mellitus Intervention:   Other: Pharmaceutical care and insulin staging. Sponsor:   University of Sulaimani Recruiting https://clinicaltrials.gov/ct2/show/NCT05244200?term=diabetes&sfpd_d=14 February 17, 2022 at 02:23PM via ClinicalTrials.gov New diabetes clinical trial: Digital Lifestyle Intervention For Diabetes/Pre-Diabetes Published on: February 18, 2022 at 07:00PM Conditions:   Type 2 Diabetes;   PreDiabetes;   Obesity Interventions:   Behavioral: Digital Intensive Lifestyle Intervention;   Behavioral: Digital Self-Help Control Condition Sponsor:   The University of Hong Kong Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05247437?term=diabetes&sfpd_d=14 February 18, 2022 at 03:22PM via ClinicalTrials.gov

Weekly Digest: a new vulnerability is published on the National Vulnerability Database (42 items)

New vulnerabilities from the NVD: CVE-2021-43943 Affected versions of Atlassian Jira Service Management Server and Data Center allow attackers with administrator privileges to inject arbitrary HTML or JavaScript via a Cross-Site Scripting (XSS) vulnerability in the "Object Schema" field of /secure/admin/InsightDefaultCustomFieldConfig.jspa. The affected versions are before version 4.21.0. Published at: February 24, 2022 at 07:15AM View on website February 24, 2022 at 08:33AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-35689 A potential vulnerability in the Oracle Talent Acquisition Cloud - Taleo Enterprise Edition. This high severity potential vulnerability allows attackers to perform remote code execution on Taleo Enterprise Edition system. Successful attacks of this vulnerability can result in unauthorized remote code execution within Taleo Enterprise Edition and unauthorized ability to cause a partial denial of service (partial DOS) of Oracle Talent Acquisition Cloud - Taleo Enterprise Edition. All affected customers were notified of CVE-2021-35689 by Oracle. Published at: February 24, 2022 at 05:15AM View on website February 24, 2022 at 08:33AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-26092 Failure to sanitize input in the SSL VPN web portal of FortiOS 5.2.10 through 5.2.15, 5.4.0 through 5.4.13, 5.6.0 through 5.6.14, 6.0.0 through 6.0.12, 6.2.0 through 6.2.7, 6.4.0 through 6.4.4; and FortiProxy 1.2.0 through 1.2.9, 2.0.0 through 2.0.1 may allow a remote unauthenticated attacker to perform a reflected Cross-site Scripting (XSS) attack by sending a request to the error page with malicious GET parameters. Published at: February 24, 2022 at 05:15AM View on website February 24, 2022 at 08:33AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-3876 ** REJECT ** DO NOT USE THIS CANDIDATE NUMBER. ConsultIDs: none. Reason: The CNA or individual who requested this candidate did not associate it with any vulnerability during 2021. Notes: none. Published at: February 24, 2022 at 05:15PM View on website February 24, 2022 at 07:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-3873 ** REJECT ** DO NOT USE THIS CANDIDATE NUMBER. ConsultIDs: none. Reason: The CNA or individual who requested this candidate did not associate it with any vulnerability during 2021. Notes: none. Published at: February 24, 2022 at 05:15PM View on website February 24, 2022 at 07:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-3871 ** REJECT ** DO NOT USE THIS CANDIDATE NUMBER. ConsultIDs: none. Reason: The CNA or individual who requested this candidate did not associate it with any vulnerability during 2021. Notes: none. Published at: February 24, 2022 at 05:15PM View on website February 24, 2022 at 07:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-3870 ** REJECT ** DO NOT USE THIS CANDIDATE NUMBER. ConsultIDs: none. Reason: The CNA or individual who requested this candidate did not associate it with any vulnerability during 2021. Notes: none. Published at: February 24, 2022 at 05:15PM View on website February 24, 2022 at 07:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-3868 ** REJECT ** DO NOT USE THIS CANDIDATE NUMBER. ConsultIDs: none. Reason: The CNA or individual who requested this candidate did not associate it with any vulnerability during 2021. Notes: none. Published at: February 24, 2022 at 05:15PM View on website February 24, 2022 at 07:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-3867 ** REJECT ** DO NOT USE THIS CANDIDATE NUMBER. ConsultIDs: none. Reason: The CNA or individual who requested this candidate did not associate it with any vulnerability during 2021. Notes: none. Published at: February 24, 2022 at 05:15PM View on website February 24, 2022 at 07:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-25636 LibreOffice supports digital signatures of ODF documents and macros within documents, presenting visual aids that no alteration of the document occurred since the last signing and that the signature is valid. An Improper Certificate Validation vulnerability in LibreOffice allowed an attacker to create a digitally signed ODF document, by manipulating the documentsignatures.xml or macrosignatures.xml stream within the document to contain both "X509Data" and "KeyValue" children of the "KeyInfo" tag, which when opened caused LibreOffice to verify using the "KeyValue" but to report verification with the unrelated "X509Data" value. This issue affects: The Document Foundation LibreOffice 7.2 versions prior to 7.2.5. Published at: February 24, 2022 at 05:15PM View on website February 24, 2022 at 07:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-27467 A Directory Traversal vulnerability exits in Processwire CMS before 2.7.1 via the download parameter to index.php. Published at: February 24, 2022 at 05:15PM View on website February 24, 2022 at 07:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2019-25058 An issue was discovered in USBGuard before 1.1.0. On systems with the usbguard-dbus daemon running, an unprivileged user could make USBGuard allow all USB devices to be connected in the future. Published at: February 24, 2022 at 05:15PM View on website February 24, 2022 at 07:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-26252 A flaw was found in htmldoc in v1.9.12. Heap buffer overflow in pspdf_prepare_page(),in ps-pdf.cxx may lead to execute arbitrary code and denial of service. Published at: February 24, 2022 at 09:15PM View on website February 24, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-14504 The web interface of the 1734-AENTR communication module mishandles authentication for HTTP POST requests. A remote, unauthenticated attacker can send a crafted request that may allow for modification of the configuration settings. Published at: February 24, 2022 at 09:15PM View on website February 24, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-14502 The web interface of the 1734-AENTR communication module is vulnerable to stored XSS. A remote, unauthenticated attacker could store a malicious script within the web interface that, when executed, could modify some string values on the homepage of the web interface. Published at: February 24, 2022 at 09:15PM View on website February 24, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-14481 The DeskLock tool provided with FactoryTalk View SE uses a weak encryption algorithm that may allow a local, authenticated attacker to decipher user credentials, including the Windows user or Windows DeskLock passwords. If the compromised user has an administrative account, an attacker could gain full access to the user’s operating system and certain components of FactoryTalk View SE. Published at: February 24, 2022 at 09:15PM View on website February 24, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-14480 Due to usernames/passwords being stored in plaintext in Random Access Memory (RAM), a local, authenticated attacker could gain access to certain credentials, including Windows Logon credentials. Published at: February 24, 2022 at 09:15PM View on website February 24, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-14478 A local, authenticated attacker could use an XML External Entity (XXE) attack to exploit weakly configured XML files to access local or remote content. A successful exploit could potentially cause a denial-of-service condition and allow the attacker to arbitrarily read any local file via system-level services. Published at: February 24, 2022 at 09:15PM View on website February 24, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-10640 Emerson OpenEnterprise versions through 3.3.4 may allow an attacker to run an arbitrary commands with system privileges or perform remote code execution via a specific communication service. Published at: February 24, 2022 at 09:15PM View on website February 24, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-10636 Inadequate encryption may allow the passwords for Emerson OpenEnterprise versions through 3.3.4 user accounts to be obtained. Published at: February 24, 2022 at 09:15PM View on website February 24, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-10635 Simulation models for KUKA.Sim Pro version 3.1 are hosted by a server maintained by KUKA. When these devices request a model, the server transmits the model in plaintext. Published at: February 24, 2022 at 09:15PM View on website February 24, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-10632 Inadequate folder security permissions in Emerson OpenEnterprise versions through 3.3.4 may allow modification of important configuration files, which could cause the system to fail or behave in an unpredictable manner. Published at: February 24, 2022 at 09:15PM View on website February 24, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-23495 The package karma before 6.3.16 are vulnerable to Open Redirect due to missing validation of the return_url query parameter. Published at: February 25, 2022 at 10:15PM View on website February 25, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-22489 There is a DoS vulnerability in smartphones. Successful exploitation of this vulnerability may affect service availability. Published at: February 25, 2022 at 09:15PM View on website February 25, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-22480 The interface of a certain HarmonyOS module has an integer overflow vulnerability. Successful exploitation of this vulnerability may lead to heap memory overflow. Published at: February 25, 2022 at 09:15PM View on website February 25, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-22479 The interface of a certain HarmonyOS module has an invalid address access vulnerability. Successful exploitation of this vulnerability may lead to kernel crash. Published at: February 25, 2022 at 09:15PM View on website February 25, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-22478 The interface of a certain HarmonyOS module has a UAF vulnerability. Successful exploitation of this vulnerability may lead to information leakage. Published at: February 25, 2022 at 09:15PM View on website February 25, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-22448 There is an improper verification vulnerability in smartphones. Successful exploitation of this vulnerability may cause unauthorized read and write of some files. Published at: February 25, 2022 at 09:15PM View on website February 25, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-22441 Some Huawei products have an integer overflow vulnerability. Successful exploitation of this vulnerability may lead to kernel crash. Published at: February 25, 2022 at 09:15PM View on website February 25, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-22437 There is a software integer overflow leading to a TOCTOU condition in smartphones. Successful exploitation of this vulnerability may cause random address access. Published at: February 25, 2022 at 09:15PM View on website February 25, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-22434 There is a memory address out of bounds vulnerability in smartphones. Successful exploitation of this vulnerability may cause malicious code to be executed. Published at: February 25, 2022 at 09:15PM View on website February 25, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-22433 There is a memory address out of bounds in smartphones. Successful exploitation of this vulnerability may cause malicious code to be executed. Published at: February 25, 2022 at 09:15PM View on website February 25, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-22432 There is a vulnerability when configuring permission isolation in smartphones. Successful exploitation of this vulnerability may cause out-of-bounds access. Published at: February 25, 2022 at 09:15PM View on website February 25, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-22431 There is a vulnerability when configuring permission isolation in smartphones. Successful exploitation of this vulnerability may cause out-of-bounds access. Published at: February 25, 2022 at 09:15PM View on website February 25, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-22430 There is a logic bypass vulnerability in smartphones. Successful exploitation of this vulnerability may cause code injection. Published at: February 25, 2022 at 09:15PM View on website February 25, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-22429 There is a memory address out of bounds in smartphones. Successful exploitation of this vulnerability may cause malicious code to be executed. Published at: February 25, 2022 at 09:15PM View on website February 25, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-22426 There is a memory address out of bounds in smartphones. Successful exploitation of this vulnerability may cause malicious code to be executed. Published at: February 25, 2022 at 09:15PM View on website February 25, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-22395 There is a code injection vulnerability in smartphones. Successful exploitation of this vulnerability may affect service confidentiality. Published at: February 25, 2022 at 09:15PM View on website February 25, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-22394 There is a buffer overflow vulnerability in smartphones. Successful exploitation of this vulnerability may cause DoS of the apps during Multi-Screen Collaboration. Published at: February 25, 2022 at 09:15PM View on website February 25, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2021-22319 There is an improper verification vulnerability in smartphones. Successful exploitation of this vulnerability may cause integer overflows. Published at: February 25, 2022 at 09:15PM View on website February 25, 2022 at 11:33PM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-36516 An issue was discovered in the Linux kernel through 5.16.11. The mixed IPID assignment method with the hash-based IPID assignment policy allows an off-path attacker to inject data into a victim's TCP session or terminate that session. Published at: February 26, 2022 at 06:15AM View on website February 26, 2022 at 08:33AM via National Vulnerability Database New vulnerabilities from the NVD: CVE-2020-27958 The Job Composer app in Ohio Supercomputer Center Open OnDemand before 1.7.19 and 1.8.x before 1.8.18 allows remote authenticated users to provide crafted input in a job template. Published at: February 26, 2022 at 10:15PM View on website February 26, 2022 at 11:33PM via National Vulnerability Database

Weekly Digest: New diabetes clinical trial (14 items)

New diabetes clinical trial: Efficacy, Safety and Pharmacokinetics Study of CPL207280 After 2-weeks Administration in Subjects With Type 2 Diabetes Published on: February 21, 2022 at 07:00PM Condition:   Type 2 Diabetes Interventions:   Drug: CPL207280;   Drug: Placebo Sponsors:   Celon Pharma SA;   National Center for Research and Development, Poland Recruiting https://clinicaltrials.gov/ct2/show/NCT05248776?term=diabetes&sfpd_d=14 February 21, 2022 at 03:22PM via ClinicalTrials.gov New diabetes clinical trial: "Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan." Published on: February 22, 2022 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   Weight Change, Body Intervention:   Drug: Semaglutide Pen Injector Sponsors:   Aga Khan University;   Rehman Medical Institute - RMI Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05249881?term=diabetes&sfpd_d=14 February 22, 2022 at 02:23PM via ClinicalTrials.gov New diabetes clinical trial: The Evaluation of Laser Lancing Devices in Adult Type 2 Diabetes Patients Published on: February 22, 2022 at 07:00PM Condition:   Type 2 Diabetes Intervention:   Device: laser lancing device or lancet for blood glucose level measurement Sponsors:   Korea University Guro Hospital;   Korea Medical Device Development Fund Recruiting https://clinicaltrials.gov/ct2/show/NCT05251506?term=diabetes&sfpd_d=14 February 22, 2022 at 02:23PM via ClinicalTrials.gov New diabetes clinical trial: Altered Faecal Microbiome and Metabolome in CT1D, AT1D and T2D Published on: February 23, 2022 at 07:00PM Condition:   Type 1 Diabetes Mellitus Maturity Onset Intervention:   Sponsor:   Second Xiangya Hospital of Central South University Recruiting https://clinicaltrials.gov/ct2/show/NCT05252728?term=diabetes&sfpd_d=14 February 23, 2022 at 05:22PM via ClinicalTrials.gov New diabetes clinical trial: Effect of Education Based on The Health Belief Model on Healthy Lifestyle Behaviors in Individuals With Type 2 Diabetes Published on: February 23, 2022 at 07:00PM Condition:   Type 2 Diabetes Intervention:   Behavioral: Education based on the health belief model Sponsor:   Gazi University Active, not recruiting https://clinicaltrials.gov/ct2/show/NCT05252793?term=diabetes&sfpd_d=14 February 23, 2022 at 05:22PM via ClinicalTrials.gov New diabetes clinical trial: The Effect of Sensorial Biodex Balance Balance System Exercises in Diabetic Neuropathy Published on: February 24, 2022 at 07:00PM Conditions:   Diabetic Neuropathies;   Diabetes Mellitus;   Exercise Training Intervention:   Device: Biodex Balance Exercise System Sponsor:   Duygu AKTAR REYHANIOGLU Completed https://clinicaltrials.gov/ct2/show/NCT05255497?term=diabetes&sfpd_d=14 February 24, 2022 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: The Dietary Guidelines 3 Diet Patterns Study (DG3D): Phase 2 Published on: February 24, 2022 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   Obesity Intervention:   Behavioral: Dietary Intervention Classes Sponsor:   University of South Carolina Recruiting https://clinicaltrials.gov/ct2/show/NCT05254496?term=diabetes&sfpd_d=14 February 24, 2022 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease)... Published on: February 24, 2022 at 07:00PM Conditions:   Type 2 Diabetes Mellitus;   Chronic Kidney Disease Interventions:   Drug: Finerenone (Kerendia, BAY94-8862 );   Drug: Empagliflozin;   Drug: Placebo Sponsor:   Bayer Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05254002?term=diabetes&sfpd_d=14 February 24, 2022 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: Safety and Efficacy of Human Microbiota Transplantation for Overweight and Obese Type 2 Diabetes Mellitus Published on: February 24, 2022 at 07:00PM Conditions:   Type 2 Diabetes Mellitus;   Overweight and Obesity Interventions:   Biological: Fecal microbiota transplant (FMT);   Other: normal saline and glycerin/food coloring Sponsors:   Zhujiang Hospital;   First Affiliated Hospital of Shantou University Medical College;   Dongguan People's Hospital;   Shenzhen Hengsheng Hospital;   The Fifth People's Hospital of Zhuhai;   Dongguan Wanjiang Hospital;   Shaoguan Qide Hospital;   People's Hospital of Wengyuan County, Shaoguan;   Zhaoqing First People's Hospital;   Suixi Hospital of Guangdong Medical University;   Shenzhen University General Hospital Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05253768?term=diabetes&sfpd_d=14 February 24, 2022 at 02:22PM via ClinicalTrials.gov New diabetes clinical trial: Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions (AP@Home04_Phase 4) Published on: February 25, 2022 at 07:00PM Condition:   Type 1 Diabetes Interventions:   Device: Hybrid closed-loop using ultra-rapid insulin lispro;   Device: Hybrid closed-loop using standard insulin lispro Sponsor:   University of Cambridge Recruiting https://clinicaltrials.gov/ct2/show/NCT05257460?term=diabetes&sfpd_d=14 February 25, 2022 at 06:22PM via ClinicalTrials.gov New diabetes clinical trial: An Analysis to Assess Non-adherence in People With Type 2 Diabetes Published on: February 25, 2022 at 07:00PM Conditions:   Diabetes Mellitus, Type 2;   Hypertension;   Medication Adherence Intervention:   Other: chemical adherence test, medication adherence questionnaire, pharmacy refill rate Sponsor:   University of Leicester Not yet recruiting https://clinicaltrials.gov/ct2/show/NCT05256875?term=diabetes&sfpd_d=14 February 25, 2022 at 06:22PM via ClinicalTrials.gov New diabetes clinical trial: SomaSignal Tests on Medical Management and Change in Risk in Patients With Diabetes Published on: February 25, 2022 at 07:00PM Condition:   Diabetes Mellitus, Type 2 Interventions:   Diagnostic Test: SomaSignal Informed Medical Management SSCVD;   Other: Standard of Care Sponsors:   Emory University;   SomaLogic, Inc. Recruiting https://clinicaltrials.gov/ct2/show/NCT05256706?term=diabetes&sfpd_d=14 February 25, 2022 at 06:22PM via ClinicalTrials.gov New diabetes clinical trial: Exercise Timing and Gestational Diabetes Published on: February 25, 2022 at 07:00PM Conditions:   Pregnancy Related;   Diabetes;   Diabete Mellitus;   Type 2 Diabetes;   Pre-diabetes;   Exercise Interventions:   Behavioral: 30-minute walking intervention;   Behavioral: 10-minute Sponsor:   University of Alberta Recruiting https://clinicaltrials.gov/ct2/show/NCT05256615?term=diabetes&sfpd_d=14 February 25, 2022 at 06:22PM via ClinicalTrials.gov New diabetes clinical trial: Investigation of Critically Ill Patients With Newly Diagnosed Diabetes Published on: February 25, 2022 at 07:00PM Condition:   Diabetes Mellitus Intervention:   Diagnostic Test: Diabetes Diagnosis Sponsor:   Stamford Hospital Completed https://clinicaltrials.gov/ct2/show/NCT05256043?term=diabetes&sfpd_d=14 February 25, 2022 at 06:22PM via ClinicalTrials.gov